Are you looking for a stock?

Try one of these

U.S. News

Verizon and unions reach tentative deal to end labour strike
Verizon Communications Inc and unions representing nearly 40,000 wireline workers have reached a tentative deal to end a strike that has stretched for more than month, U.S. Secretary of Labour Thomas Perez said on Friday.
Posted on 5-27-2016 at 2:05 PM
Monsanto boss could net US$70 million from a Bayer takeover
Monsanto boss Hugh Grant could land more than $70 million if the world's largest seed company is taken over by German chemicals giant Bayer AG.
Posted on 5-27-2016 at 1:03 PM
Valeant Pharmaceuticals said to reject a takeover approach
A series of scandals at Valeant apparently wasn’t enough to scare off suitors. The drugmaker reportedly swatted away a takeover offer by Takeda Pharmaceutical and TPG in the spring.
Posted on 5-27-2016 at 10:29 AM
Gawker exploring a sale following Hulk Hogan case
Gawker Media, the New York-based owner of online news and gossip website, is exploring a sale following a court ruling that it pay $140 million to wrestler Hulk Hogan over the publication of a sex tape, the New York Post reported.
Posted on 5-26-2016 at 11:42 AM
Fed survey lays bare U.S. economic divide
Almost half of American families say they would struggle to pay for emergency expenses and those with a high school degree or less are most likely to say their well-being has declined, according to a Federal Reserve survey released on Wednesday.
Posted on 5-25-2016 at 1:47 PM
Valeant CEO vows to lower debt by more than US$1.5B in 2016
Valeant Pharmaceuticals Inc plans to lower its debt by at least $1.5 billion this year, Chief Executive Officer Joseph Papa said on Monday during his first large meeting with investors since taking the top job three weeks ago.
Posted on 5-24-2016 at 7:43 AM
Is Valeant Bill Ackman’s 'Waterloo?'
At least one money manager isn't buying Bill Ackman’s claims to have cleaned up the situation at Valeant, the troubled pharmaceutical company.
Posted on 5-12-2016 at 12:25 PM
Key player in Pershing Square's Valeant bet leaving firm
William Doyle, a key figure in Pershing Square Capital Management's controversial investment in battered drug company Valeant Pharmaceuticals, is leaving the hedge fund, its founder, William Ackman, told investors on Wednesday.
Posted on 5-12-2016 at 8:15 AM

News by Sector

Today's Guests CTV Two CTV News CTV News Channel BNN - Business News Network CP24